Multifunctional polyurethane-urea nanoparticles to target and arrest inflamed vascular environment: a potential tool for cancer therapy and diagnosis.

[1]  C. Solans,et al.  Design of biocompatible surface-modified polyurethane and polyurea nanoparticles , 2012 .

[2]  Molly M Stevens,et al.  Synthesis of two-component injectable polyurethanes for bone tissue engineering. , 2007, Biomaterials.

[3]  C. Solans,et al.  Formation of polymeric nano-emulsions by a low-energy method and their use for nanoparticle preparation. , 2011, Journal of colloid and interface science.

[4]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[5]  T. Wagner,et al.  Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor , 2004, Cancer Gene Therapy.

[6]  J. L. Smith,et al.  Crystal structure of core streptavidin determined from multiwavelength anomalous diffraction of synchrotron radiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Chang Chen,et al.  Radical mediastinal nodal removal improves disease-free survival for pulmonary low-grade malignant tumors. , 2012, Lung cancer.

[8]  Seho Kim,et al.  Polyoxalate nanoparticles as a biodegradable and biocompatible drug delivery vehicle. , 2010, Biomacromolecules.

[9]  M. Hersam,et al.  Biomolecule-directed assembly of self-supported, nanoporous, conductive, and luminescent single-walled carbon nanotube scaffolds. , 2012, Small.

[10]  G. Rabinovich,et al.  Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.

[11]  C. Solans,et al.  Formation of Pegylated polyurethane and Lysine-coated polyurea nanoparticles obtained from O/W nano-emulsions. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[12]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[13]  A. Karsan,et al.  Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. , 2003, Blood.

[14]  F. Kiessling,et al.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  K. F. Perry,et al.  Metabolic biotinylation of cell surface receptors for in vivo imaging , 2006, Nature Methods.

[16]  A. Karsan,et al.  Lipopolysaccharide signaling in endothelial cells , 2006, Laboratory Investigation.

[17]  F. Caruso,et al.  Challenges facing colloidal delivery systems: From synthesis to the clinic , 2011 .

[18]  J. Conde,et al.  Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. , 2012, ACS nano.

[19]  K. Raju,et al.  Synthesis and characterization of hyperbranched polyurethane–urea coatings , 2007 .

[20]  G. Vlastos,et al.  Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Nguyen,et al.  Multifunctional particles for melanoma-targeted drug delivery. , 2012, Acta biomaterialia.

[22]  A. Bikfalvi,et al.  Structure and Inhibitory Effects on Angiogenesis and Tumor Development of a New Vascular Endothelial Growth Inhibitor* , 2003, Journal of Biological Chemistry.

[23]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[24]  P. Lin,et al.  Angiogenesis links chronic inflammation with cancer. , 2009, Methods in molecular biology.

[25]  M. Howarth,et al.  Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase , 2005, Nature Methods.

[26]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[27]  D. Orringer,et al.  IN VITRO CHARACTERIZATION OF A TARGETED, DYE‐LOADED NANODEVICE FOR INTRAOPERATIVE TUMOR DELINEATION , 2009, Neurosurgery.

[28]  Esther J Kim,et al.  Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages. , 2013, Biomaterials.

[29]  O. Ganslandt,et al.  Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach , 2012, PloS one.

[30]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[31]  P. Yu,et al.  In vitro cytotoxicity, hemolysis assay, and biodegradation behavior of biodegradable poly(3-hydroxybutyrate)-poly(ethylene glycol)-poly(3-hydroxybutyrate) nanoparticles as potential drug carriers. , 2008, Journal of biomedical materials research. Part A.

[32]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[33]  M. Winnik,et al.  Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment. , 2012, Biomacromolecules.

[34]  S. Mariathasan,et al.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation , 2007, Nature Reviews Immunology.

[35]  Cristina Airoldi,et al.  Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease. , 2012, ACS nano.

[36]  P. Angel,et al.  The receptor RAGE: Bridging inflammation and cancer , 2009, Cell Communication and Signaling.

[37]  Po-Chiao Lin,et al.  A chemically functionalized magnetic nanoplatform for rapid and specific biomolecular recognition and separation. , 2013, Biomacromolecules.

[38]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[39]  L. Boscá,et al.  ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration. , 2010, Cardiovascular research.

[40]  Rakesh K. Jain,et al.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases , 2011, Nature Reviews Drug Discovery.

[41]  Iseult Lynch,et al.  Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[42]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[43]  M. Mitjans,et al.  In vitro studies of the hemolytic activity of microemulsions in human erythrocytes. , 2005, Journal of pharmaceutical and biomedical analysis.

[44]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[45]  Wei Zhang,et al.  Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers , 2012, PloS one.

[46]  Yong-Eun Koo Lee,et al.  Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranostics--a "see and treat" strategy. , 2012, ACS nano.

[47]  Peter Gluchowski,et al.  F , 1934, The Herodotus Encyclopedia.

[48]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[49]  Holger Gerhardt,et al.  Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.

[50]  L. Wilkinson.  Immunity , 1891, The Lancet.

[51]  R. Salvayre,et al.  Colloidal systems for drug delivery: from design to therapy. , 2012, Trends in biotechnology.